Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01612026 · ClinicalTrials.gov registry record
Ultrasound Versus Fluoroscopically-guided Arterial Access in Non-cardiac Vascular Patients
A clinical trial, sponsored by CAMC Health System.
- Completed
- Registry status
- 643
- Enrollment target
NCT01612026: Completed study, sponsored by CAMC Health System.
NCT01612026 is a clinical trial that has completed, run by CAMC Health System. The registered enrollment target is 643 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01612026 has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- 643 participants
- Enrollment target
Study Summary
In the investigators vascular practice, either fluoroscopic- or ultrasound-guided technique is routinely used to obtain femoral arterial access. Ultrasound-guidance is frequently used in patients with weak or absent pulses, known abnormal vascular anatomy, need for bypass graft puncture, and to ensure accurate arterial puncture in patients expected to receive large doses of blood-thinning medications during or after the procedure. For those practitioners experienced with ultrasound-guided access techniques, it is considered highly accurate and easy to use; thus, some physicians routinely use this tool. A well-designed study is needed to truly assess the accuracy of the ultrasound technique and to determine whether it may reduce complications of arterial access in vascular patients. By demonstrating the safest, most accurate and efficient technique for obtaining arterial access during catheter-based procedures, the investigators could significantly reduce morbidity and mortality associated with complications of arterial puncture. Length of hospital stay, management costs and patient discomfort could be reduced by minimizing complication rates.
Interventions
- PROCEDURE arterial cannulation by angiographic imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 643 participants |
| Start Date | 2013-03 |
| Est. Completion | 2017-10 |
What the finished NCT01612026 record still lists
NCT01612026 is an observational study that tracks outcomes without assigning an intervention. The registered 643 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which arterial cannulation by angiographic imaging is the first listed.
NCT01612026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01612026 about?
NCT01612026 is a clinical study titled "Ultrasound Versus Fluoroscopically-guided Arterial Access in Non-cardiac Vascular Patients". In the investigators vascular practice, either fluoroscopic- or ultrasound-guided technique is routinely used to obtain femoral arterial access. Ultrasound-guidance is frequently used in patients with weak or absent pulses, known abnormal vascular anatomy, need for bypass graft puncture, and to ensu...
What is the current status of trial NCT01612026?
This trial is currently completed. The enrollment target is 643 participants. The study started on 2013-03. Estimated completion is 2017-10.
What interventions are being tested in trial NCT01612026?
The interventions under investigation include: arterial cannulation by angiographic imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01612026?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
- NCT06994442 · 644 participants · Phase 3
Optimizing Pain Treatment in Children On Mechanical Ventilation
- NCT05204888 · 642 participants · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia